Brent Saunders pivots from Allergan sale to a $460M SPAC, making him an overnight player in one of the hottest money-raising gambits in biotech
It was only a matter of time before Brent Saunders started wheeling and dealing again. And what better vehicle to choose for his first serious endeavor than a blank check company?
All the rage in biotech financial services these days, Saunders has formed a special purpose acquisition company called Vesper Healthcare Acquisition aimed at raising $460 million plus for some biopharma company looking to gin cash and quick recognition with a leap into Nasdaq.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.